Juerg Lehmann

433 total citations
13 papers, 242 citations indexed

About

Juerg Lehmann is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Juerg Lehmann has authored 13 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Surgery. Recurrent topics in Juerg Lehmann's work include Receptor Mechanisms and Signaling (4 papers), Diabetes Treatment and Management (3 papers) and Pancreatic function and diabetes (3 papers). Juerg Lehmann is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Diabetes Treatment and Management (3 papers) and Pancreatic function and diabetes (3 papers). Juerg Lehmann collaborates with scholars based in United States, Denmark and Germany. Juerg Lehmann's co-authors include Robert M. Jones, Daniel J. Buzard, James Leonard, Kenneth G. Strothkamp, Maja S. Engelstoft, Stephen J. Lippard, M. Hauge, Thomas M. Frimurer, Christoffer Norn and Thue W. Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Juerg Lehmann

13 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juerg Lehmann United States 7 136 131 80 51 44 13 242
Run Zhuang United States 8 248 1.8× 224 1.7× 164 2.0× 66 1.3× 29 0.7× 11 353
Marc Vimolratana United States 8 241 1.8× 184 1.4× 163 2.0× 66 1.3× 141 3.2× 23 452
Corey Miller United States 7 180 1.3× 172 1.3× 103 1.3× 41 0.8× 43 1.0× 7 378
Kathy Nguyen United States 5 237 1.7× 204 1.6× 217 2.7× 70 1.4× 9 0.2× 5 366
Jasminka Dragovic United States 7 105 0.8× 158 1.2× 52 0.7× 132 2.6× 32 0.7× 7 338
Maria A. VanVolkenburg United States 10 146 1.1× 104 0.8× 64 0.8× 42 0.8× 54 1.2× 12 273
Mette Lund Pedersen Denmark 5 192 1.4× 88 0.7× 44 0.6× 83 1.6× 25 0.6× 9 399
Eugenia Sergeev United Kingdom 8 227 1.7× 51 0.4× 63 0.8× 97 1.9× 14 0.3× 13 304
M. F. Sammons United States 9 106 0.8× 80 0.6× 46 0.6× 17 0.3× 182 4.1× 18 321
Lesley A. McNamara United States 7 99 0.7× 67 0.5× 38 0.5× 9 0.2× 25 0.6× 8 202

Countries citing papers authored by Juerg Lehmann

Since Specialization
Citations

This map shows the geographic impact of Juerg Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juerg Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juerg Lehmann more than expected).

Fields of papers citing papers by Juerg Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juerg Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juerg Lehmann. The network helps show where Juerg Lehmann may publish in the future.

Co-authorship network of co-authors of Juerg Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Juerg Lehmann. A scholar is included among the top collaborators of Juerg Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juerg Lehmann. Juerg Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ren, Albert, Xiuwen Zhu, Juerg Lehmann, et al.. (2025). Diazepine Agonists of the 5-HT2C Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352). Journal of Medicinal Chemistry. 68(11). 10599–10618. 2 indexed citations
2.
Gonçalves, L.M., et al.. (2024). BioPrint Meets the AI Age: Development of Artificial Intelligence-Based ADMET Models for the Drug-Discovery Platform SAFIRE. Future Medicinal Chemistry. 16(7). 587–599. 2 indexed citations
3.
Norn, Christoffer, M. Hauge, Maja S. Engelstoft, et al.. (2015). Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening. Structure. 23(12). 2377–2386. 7 indexed citations
4.
Buzard, Daniel J., Thomas O. Schrader, Xiuwen Zhu, et al.. (2014). Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor. Bioorganic & Medicinal Chemistry Letters. 25(3). 659–663. 13 indexed citations
5.
Engelstoft, Maja S., Christoffer Norn, M. Hauge, et al.. (2014). Structural basis for constitutive activity and agonist‐induced activation of the enteroendocrine fat sensor GPR119. British Journal of Pharmacology. 171(24). 5774–5789. 25 indexed citations
6.
Buzard, Daniel J., Juerg Lehmann, Sangdon Han, & Robert M. Jones. (2012). GPR119 Agonists 2009–2011. Pharmaceutical Patent Analyst. 1(3). 285–299. 8 indexed citations
7.
Semple, Graeme, Juerg Lehmann, Albert Ren, et al.. (2011). Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile. Bioorganic & Medicinal Chemistry Letters. 22(4). 1750–1755. 39 indexed citations
8.
Jones, Robert M., James Leonard, Daniel J. Buzard, & Juerg Lehmann. (2009). GPR119 agonists for the treatment of type 2 diabetes. Expert Opinion on Therapeutic Patents. 19(10). 1339–1359. 124 indexed citations
9.
Dosa, Peter I., Martin D. Casper, Yifeng Xiong, et al.. (2009). Solubilized phenyl-pyrazole ureas as potent, selective 5-HT2A inverse-agonists and their application as antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 19(18). 5486–5489. 6 indexed citations
10.
Decker, Michael & Juerg Lehmann. (2006). LE300--new results on its ability to antagonize the discriminative stimulus effects of cocaine.. PubMed. 61(3). 248–50. 1 indexed citations
11.
Lehmann, Juerg, et al.. (1997). SYNTHESIS AND BIOLOGICAL ACTIVITY OF NITROOXYMETHYL- AND NITROOXYACYLOXY-PHENYL-l,4-DIHYDROPYRIDINES. The Japanese Journal of Pharmacology. 75. 107–107. 1 indexed citations
12.
Nieger, Martin, et al.. (1995). EPC-Synthese, Struktur und Pharmakologie lactonisierter und lactamisierter Acetylcholin-Analoga : Lactone. XXVIII. Pharmazie. 50(1). 15–21. 1 indexed citations
13.
Strothkamp, Kenneth G., Juerg Lehmann, & Stephen J. Lippard. (1978). Tetrakis(acetoxymercuri)methane: a polymetallic reagent for labeling sulfur in nucleic acids.. Proceedings of the National Academy of Sciences. 75(3). 1181–1184. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026